Skip to Main Content
Lantern_Icon_blue
Lantern by Labaton
Link_Arrow
ClientConnect_Icon_blue
Client Connect
Link_Arrow
Labaton Logo
  • The Firm
  • Practices
  • Our Team
  • Cases
  • News & Insights
  • Client Services
  • Careers
Contact Us
Established 1963

Back to Resolved Cases
Practice Area: Securities Litigation
Updated: October 5, 2016

In re Nu Skin Enterprises, Inc., Securities Litigation

Case Materials

Consolidated Complaint
Proof of Claim
Notice
Stipulation of Settlement
Declaration of Jonathan Gardner with Exhibits
Fee Brief
Final Approval Brief
Fee Order
Order Approving Plan of Allocation
Final Order and Judgement

Labaton Keller Sucharow was the sole appointed lead counsel in the securities fraud case against Nu Skin Enterprises, Inc (Nu Skin), a direct selling and multilevel marketing company that develops and sells personal and nutritional supplement packets.

The plaintiffs alleged that Nu Skin misled its investors and failed to disclose material facts about the success and viability of Nu Skin's business model and business practices in China; specifically, that: (1) Nu Skin's business practices violated Chinese laws and regulations; and (2) Nu Skin's rapid expansion and growth in revenues could not continue without its Chinese operations.

After two hours of oral argument, the court denied Nu Skin's motion to dismiss from the bench on February 18, 2015.  On February 22, 2016, Labaton Keller Sucharow secured a $47 million settlement, which was then granted preliminary approval on May 24, 2016.

The case is In re Nu Skin Enterprises, Inc., Securities Litigation, No. 14-cv-0033 (D. Utah).  Lead plaintiff is Boston Retirement System.  The defendants are Nu Skin Enterprises, Inc.; CEO, M. Truman Hunt; and CFO, Ritch N. Wood.

Background

During the class period (October 25, 2011, to January 16, 2014), Nu Skin's Chinese operations accounted for a substantial portion of the company's revenues, and defendants repeatedly highlighted the sharp expansion of its China operations as indicative of the success and viability of its business model.  However, on August 7, 2012, a Citron Research report alleged that Nu Skin's operations in China were nothing more than a pyramid scheme based on multilevel marketing, a sales strategy prohibited in China.  On this news, Nu Skin's stock price declined $4.50 per share, or 9.21 percent, to close at $44.36 per share.  In response, Nu Skin issued a press release assuring investors that the company was "confident that [its] China operations [we]re in compliance with applicable regulations as interpreted and enforced by the government of China."

On January 15, 2014, China's largest newspaper, People's Daily, published a report asserting that Nu Skin's operations in China violated Chinese law and that the company's operations were suspected to be an illegal pyramid scheme.  The article further reported, among other things, that the company sold 104 products in China—20 more than Chinese regulations allowed.  In response to these revelations, the company's stock price fell $21.24 per share, or 15.56 percent, to close at $115.23 per share that day.  The following two days, two separate Chinese agencies announced they had started investigations into Nu Skin following the People's Daily report.  The company acknowledged the existence of the investigations, noting that its revenues could be negatively affected.  On these disclosures, the company's stock price fell 26.41 percent on January 16, 2014, and again by 6.29 percent on January 17, 2014, closing at $79.47 per share that day.

Settlement Hearing

A Settlement Hearing was held on October 5, 2016 at 2:00 p.m. in Courtroom 8.200 at the United States District Court for the Northern District of Utah, 351 South West Temple, Salt Lake City, UT 84101.  The Court approved the Settlement and related relief in full.

If you have questions about the settlement, please contact Labaton Keller Sucharow at settlementquestions@labaton.com or 1-888-219-6877, or contact the Claims Administrator, A.B. Data, Ltd., at 866-963-9975.

logo

Our Locations

New York

140 Broadway
New York, NY 10005
Tel: +1 212.907.0700

Delaware

222 Delaware Avenue, Suite 1510
Wilmington, DE 19801
Tel: +1 302.573.2540

London

1 King William Street
London, EC4N 7AF United Kingdom
Tel: +44 20 3582 0981

Washington, D.C.

1050 Connecticut Avenue NW, Suite 500
Washington, D.C. 20036
Tel: +1 202.772.1881

Useful Links

  • Practices
  • Cases
  • News & Insights
  • Client Services
  • Contact

The Firm

  • Our Team
  • Our Story
  • Awards & Accolades
  • Offices
  • Social Commitment
  • Careers for Attorneys
  • Careers for Business Professionals
  • Attorney Development

Stay Connected

fbfb
Facebook
Xx
Twitter / X
inin
LinkedIn
Footer_Graphic
© Labaton Keller Sucharow LLP All Rights Reserved 2026
Attorney Advertising DisclaimerPrivacy PolicyCookie PolicyCalifornia Privacy Policy and Notice of Collection of Personal InformationTransparency in Coverage Rule